Inhibitor Development in Previously Untreated Patients with Hemophilia A: A Prospective Long-Term Follow-Up Comparing Plasma-Derived and Recombinant Products-Reference-Cited by-同舟云学术

Inhibitor Development in Previously Untreated Patients with Hemophilia A: A Prospective Long-Term Follow-Up Comparing Plasma-Derived and Recombinant Products

Published:2002 Issue:3 Volume:28 Page:285-290
ISSN:0094-6176
Container-title:Seminars in Thrombosis and Hemostasis
language:
Short-container-title:Semin Thromb Hemost

Author:

Kreuz Wolfhart,Ettingshausen Carmen Escuriola,Zyschka Alex,Oldenburg Johannes,Saguer Inmaculada Martinez,Ehrenforth Silke,Klingebiel Thomas

Publisher

Georg Thieme Verlag KG

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2002-32664.pdf

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition;Journal of Thrombosis and Haemostasis;2022-09

2. Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China;Haemophilia;2022-05

3. Final Results of the Prospective ADVATE® Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII;Journal of Blood Medicine;2021-11

4. Recent Advances in the Treatment of Hemophilia: A Review;Biologics: Targets and Therapy;2021-06

5. Epidemiological Challenges in Rare Bleeding Disorders: FVIII Inhibitor Incidence in Haemophilia A Patients—A Known Issue of Unknown Origin;International Journal of Environmental Research and Public Health;2020-12-30